Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04564209 · ClinicalTrials.gov registry record · NA

Information Visualizations to Enhance HIV-related Communication

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
164
Enrollment target

NCT04564209 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 164 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04564209, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
164 participants
Enrollment target

Study Summary

HIV disproportionately affects Latinos who have more infections, faster disease progression, more HIV-related deaths, and slower diagnosis and treatment than their white/majority counterparts. This is a concern across the United States (US) and in developing countries, such as the Dominican Republic (DR). The HIV-related health disparities experienced by Latinos are made worse when those living with HIV have low health literacy and difficulty understanding the information they need to manage their health. The PI developed a set of images to assist clinicians in providing information to Latino people living with HIV (PLWH). These images have been put into a mobile health app so clinicians can easily access them during clinic visits. The PI has tested her with PLWH in the DR and in New York City. So, the next steps in this research are to ensure the images are relevant and useful to Latinos across the United States (US) and to further assess if, and to what extent, the images can improve health outcomes among PLWH in the US and in the DR. We will therefore, adapt images to Latinos of Mexican origin/descent and then test them to determine if these images help clinicians provide information to patients by conducting a study at clinical sites in the US and in the DR.

Interventions

  • OTHER Info Viz for Health

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2021-08-18
Est. Completion 2023-06-28
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04564209

The ClinicalTrials.gov registry entry for NCT04564209 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Info Viz for Health is the first listed.

NCT04564209 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04564209 about?

NCT04564209 is a clinical study titled "Information Visualizations to Enhance HIV-related Communication". HIV disproportionately affects Latinos who have more infections, faster disease progression, more HIV-related deaths, and slower diagnosis and treatment than their white/majority counterparts. This is a concern across the United States (US) and in developing countries, such as the Dominican Republic...

What is the current status of trial NCT04564209?

This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2021-08-18. Estimated completion is 2023-06-28.

What interventions are being tested in trial NCT04564209?

The interventions under investigation include: Info Viz for Health (OTHER).

Who is sponsoring clinical trial NCT04564209?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.